Manufacturer: Janssen Cilag
Pharmaceutical name: Canagliflozin
Pack: 10 pills (100 mg)
Invokana is a sodium-glucose cotransporter 2 (SGLT2) inhibitor prescribed for managing type-2 diabetes mellitus in adults. Each tablet contains 100 mg of the active compound Canagliflozin. Canagliflozin aids in regulating diabetes by reducing the absorption of sugar in the body and increasing the amount of sugar expelled in the urine.
It is important to follow the dosing instructions given by your healthcare provider. Regular blood tests may be arranged to ensure that Invokana is effective, and the dosage might require adjustments. Typically, Invokana is taken before the first meal of the day. For optimal results, it is recommended to use Invokana in conjunction with a balanced diet and exercise regimen.
The most frequently reported side effect of Invokana is increased urination, as the body eliminates more sugar. If you experience any of the following symptoms while using Canagliflozin, contact your doctor immediately: severe allergic reactions (such as rash, hives, itching, difficulty breathing, tightness in the chest, swelling in the mouth, face, lips, throat, or tongue, or unusual hoarseness); fainting; genital (vagina or penis) discharge; itching, rash, pain, or irritation; irregular heartbeat; muscle weakness; severe or persistent headaches or dizziness; or signs of kidney issues or urinary tract infections.